Brandon von Kriegelstein

Brandon von Kriegelstein

Katten Muchin Rosenman LLP

Contact
View Bio
RSS

Latest Posts › Biologics

Share:

FDA Reimagined: Faster, Friendlier, and Focused on Cures

On June 10, 2025, the Commissioner of the FDA, Dr. Martin Makary, and Dr. Vinayak Prasad, the Director of the FDA’s Center for Biologics Evaluation and Research, published an article in JAMA discussing the “Priorities for a...more

6/17/2025  /  Artificial Intelligence , Biologics , Drug Pricing , Food and Drug Administration (FDA) , Healthcare Reform , Machine Learning , Medical Devices , Prescription Drugs , Public Health , Regulatory Reform
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide